Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eiko Ueda"'
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Sho Kinguchi, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Externí odkaz:
https://doaj.org/article/bc8b5ab08cbb441db2084058f0dfc4de
Autor:
Yuki Kawai, Yoshiyuki Toya, Hiromichi Wakui, Tetsuya Fujikawa, Eiko Ueda, Kengo Azushima, Hiroshi Mitsuhashi, Tomoyuki Kawano, Tadashi Kuji, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 4, Pp 870-878 (2021)
Abstract Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In
Externí odkaz:
https://doaj.org/article/62f0e25c3ca842bebc112335d5734937
Autor:
Tomoyuki Kawano, Tadashi Kuji, Tetsuya Fujikawa, Eiko Ueda, Midori Shino, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura, Nobuhito Hirawa, Yoshiyuki Toya
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-7 (2017)
Abstract Background We recently demonstrated, using an index of recently synthesized hemoglobin, reticulocyte hemoglobin (Ret-Hb), that iron administration remarkably improves hemoglobin (Hb) synthesis during the period of high activation of erythrop
Externí odkaz:
https://doaj.org/article/cd4d21e118bb473fb4ed37f0a4b7bf8b
Publikováno v:
Eye & Contact Lens: Science & Clinical Practice. 48:503-508
To assess the performance of the contact lens fitting software built into anterior segment optical coherence tomography (AS-OCT).This retrospective study enrolled patients with keratoconus prescribed with spherical corneal rigid gas-permeable contact
Autor:
Hiromichi Wakui, Hiroshi Mitsuhashi, Tetsuya Fujikawa, Kengo Azushima, Yuki Kawai, Toshimasa Ohnishi, Eiko Ueda, Tadashi Kuji, Kouichi Tamura, Yoshiyuki Toya, Sho Kinguchi, Satoshi Yamaguchi, Tomoyuki Kawano
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 118-125 (2021)
Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two thera
Autor:
Tetsuya Fujikawa, Hiromichi Wakui, Kengo Azushima, Tomoyuki Kawano, Satoshi Yamaguchi, Hiroshi Mitsuhashi, Toshimasa Ohnishi, Kouichi Tamura, Eiko Ueda, Tadashi Kuji, Yoshiyuki Toya, Yuki Kawai
Publikováno v:
The Journal of Clinical Hypertension
Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In this ran
Autor:
Yuki Kawai, Midori Kakimoto-Shino, Kengo Azushima, Eiko Ueda, Tadashi Kuji, Tomoyuki Kawano, Yoshiyuki Toya, Tetsuya Fujikawa, Hiromichi Wakui, Kouichi Tamura
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 26(5)
INTRODUCTION The erythropoietin resistance index (ERI) is an indicator of Erythropoiesis-stimulating agent (ESA) responsiveness and is typically calculated using Hb. However, Hb does not directly reflect ESA-induced erythropoiesis because of its long
Autor:
Takeharu Yamanaka, Yusuke Saigusa, Yoshiyuki Toya, Eiko Ueda, Kengo Azushima, Yuki Kawai, Yuichiro Yabuki, Taro Mikami, Hiromichi Wakui, Takayuki Fujita, Kouichi Tamura, Motohiko Goda, Teruyasu Sugano
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 24(5)
A novel approach is required for standard therapy-resistant peripheral arterial disease (PAD). This is a single-center, single-arm, interventional study (LDL Apheresis-Mediated Endothelial Activation Therapy to Severe-Peripheral Artery Disease study)
Autor:
Eiko Ueda, Toshimasa Ohnishi, Naoyuki Kobayashi, Yoshiyuki Toya, Tadashi Kuji, Yoko Itoh, Midori Shino, Nobuhito Hirawa, Tatsuo Hashimoto, Kouichi Tamura, Shota Suzuki, Tetsuya Fujikawa
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:476-484
Oxidative stress accelerates the development of cardiovascular disease. Plasma cystine, a thiol oxidative stress marker, is related to several established factors for cardiovascular disease risk and prognosis. Although a comprehensive oxidative stres
Publikováno v:
The Journal of Clinical Hypertension. 21:1295-1297